TCL科技：公司将积极推进广生中霖的增资扩股融资

Core Viewpoint - TCL Technology is actively advancing its innovative drug development platform, Guangsheng Zhonglin, which is focused on high-investment and long-cycle drug development tasks [1] Group 1: Company Strategy - The company plans to promote capital increase and share expansion financing for Guangsheng Zhonglin to secure necessary operational funds [1] - The entire research and development team is committed to efficiently advancing clinical research with high quality [1] Group 2: Goals and Impact - The company aims to expedite the market launch of innovative drugs under development to benefit patients and provide returns to investors [1]